dual JAK2/HDAC inhibitors (Shandong University/Chinese Academy of Sciences/Fudan University)

N/A

Report date: 2025/03/19 11:37:39
NME

Base Information

Drug Namedual JAK2/HDAC inhibitors (Shandong University/Chinese Academy of Sciences/Fudan University)
Drug Alias NameDiscovery of Novel Janus Kinase and Histone Deacetylase Dual Inhibitors for the Treatment of Hematological Malignancies
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsHistone deacetylase inhibitors
TargetsTyrosine-protein kinase JAK2Histone deacetylase
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong University
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesShandong UniversityFudan University
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A